Long-term safety and efficacy of teriflunomide Nine-year follow-up of the randomized TEMSO study

Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group, Raymond Hupperts

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)920-930
Number of pages11
JournalNeurology
Volume86
Issue number10
DOIs
Publication statusPublished - 8 Mar 2016

Keywords

  • RELAPSING MULTIPLE-SCLEROSIS
  • ORAL TERIFLUNOMIDE
  • DOUBLE-BLIND

Cite this